Conclusion
Despite advancements in technologies, non-uniform soft tissue attenuation still affects the diagnostic accuracy of single photon emission computed tomography (SPECT) myocardial perfusion imaging. A variety of indirect measures have been used to reduce the impact of attenuation, most notably electrocardiography-gated SPECT imaging. However, all available techniques have limitations, making interpretation in the presence of attenuation difficult. The ultimate solution, similar to positron emission tomography imaging, is to use hardware/software algorithms to eliminate attenuation and provide images that are more uniform and easier to interpret. Several attenuation correction solutions are currently available and more will be available soon. The value of these solutions has been varied, particularly with clinical applications. Guidelines and standards clearly are necessary.
In recognition of the importance of this issue, the American Society of Nuclear Cardiology and the Society of Nuclear Medicine convened a joint task force to develop a position statement on attenuation correction. It is being published concurrently in the Journal of Nuclear Cardiology and The Journal of Nuclear Medicine, a first for these societies.
The purpose of this position statement is to clarify the role of attenuation correction in SPECT procedures, to provide guidelines for its clinical use, and to provide a basis for the evaluation of published validation. It is hoped that this position statement will provide an important and useful road map to the widespread adoption of attenuation correction into clinical practice.
Similar content being viewed by others
References
Almquist H, Arheden H, Arvidsson AH, Pahlm O, Palmer J. Clinical implications of down-scatter in attenuation-corrected myocardial SPECT. J Nucl Cardiol 1999; 6: 406–11.
Chouraqui P, Livschitz S, Sharir T, Wainer N, Wilk M, Moalem I, et al. Evaluation of an attenuation correction method for thallium-201 myocardial perfusion tomographic imaging of patients with low likelihood of coronary artery disease. J Nucl Cardiol 1998; 5: 369–77.
Corbett JR, Ficaro EP. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol 1999; 6: 54–68.
Cullom SJ, Case JA, Bateman TM. Attenuation correction of cardiac SPECT: clinical and developmental challenges. J Nucl Med 2000; 41: 860–2.
DePuey EG, Garcia EV. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts. J Nucl Med 1989; 30: 441–9.
Duvernoy CS, Ficaro EP, Karabajakian MZ, Rose PA, Corbett JR. Improved detection of left main coronary artery disease with attenuation-corrected SPECT. J Nucl Cardiol 2000; 7: 639–48.
Ficaro EA, Fessler JA, Ackermann RJ, Rogers WL, Corbett JR, Schwaiger M. Simultaneous transmission-emission thallium-201 cardiac SPECT: effect of attenuation correction on myocardial tracer distribution. J Nucl Med 1995; 36: 905–6.
Ficaro EA, Fessler JA, Shreve PD, Kritzman JN, Rose PA, Corbett JR. Simultaneous transmission/emission myocardial perfusion tomography: diagnostic accuracy of attenuation corrected Tc-99m sestamibi single-photon emission computed tomography. Circulation 1996; 93: 463–73.
Ficaro E, Duvernoy C, Karabajakian M, Corbett J. Evaluation of attenuation corrected SPECT perfusion imaging in patients with multi-vessel disease [abstract]. Circulation 1997; 96: I-308.
Gallowitsch HJ, Sykora J, Mikosch P, Kresnik E, Unterweger O, Molnar M, et al. Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med 1998; 25: 220–8.
Gallowitsch HJ, Unterweger O, Mikosch P, Kresnik E, Sykora J, Grimm G, et al. Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction. Eur J Nucl Med 1999; 26: 459–66.
Garcia EV. Quantitative myocardial perfusion single-photon emission computed tomographic imaging: quo vadis? (Where do we go from here?). J Nucl Cardiol 1994; 1: 83–93.
Gerson MC, Singh BKM, Lukes J, Bauman BD. Comparison of attenuation and Compton scatter corrected to uncorrected thallium-201 tomograms for diagnosis of coronary artery disease (CAD) [abstract]. J Nucl Med 1999; 40: 89P.
Hendel RC, Berman DS, Follansbee W, Heller GV, Cullom SJ. A multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999; 99: 2742–9.
Hendel RC, Selker HR, Heller GV, Ruthazer R, Beshansky JR, Griffith JL, et al. The impact of attenuation correction and gating on SPECT perfusion imaging in patients presenting to the emergency department with chest pain [abstract]. Circulation 2000; 102: II-543.
Jaszczak RJ, Greer KL, Floyd CG, Harris CG, Coleman E. Improved SPECT quantification using compensation for scattered photons. J Nucl Med 1984; 25: 893–900.
Kadrmas DJ, Frey EC, Tsui BMW. Application of reconstruction-based scatter compensation to thallium-201 SPECT: implementations for reduced reconstruction image noise. IEEE Trans Med Imaging 1998; 17: 325–33.
King MA, Tsui BMW, Pan TS. Attenuation compensation for cardiac single-photon emission computed tomographic imaging: part 1. Impact of attenuation and methods of estimating attenuation maps. J Nucl Cardiol 1995; 2: 513–24.
King MA, Tsui BMW, Pan TS, Glick SJ, Soares EJ. Attenuation compensation for cardiac single-photon emission computed tomographic imaging: part 2. Attenuation compensation algorithms. J Nucl Cardiol 1996; 3: 55–63.
Kluge R, Sattler B, Seese A, Knapp WH. Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracy. Eur J Nucl Med 1997; 24: 1107–14.
Lacroix KJ, Tsui BMW, Frey EC, Jaszcak RJ. Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in Tc-99m sestamibi myocardial perfusion SPECT images. J Nucl Med 2000; 41: 502–13.
Lee DS, So Y, Cheon GJ, Kim KM, Lee MM, Chung JK, et al. Limited incremental diagnostic values of attenuation noncorrected gating and ungated attenuation correction to rest/stress myocardial perfusion SPECT in patients with an intermediate likelihood of coronary artery disease. J Nucl Med 2000; 41: 852–9.
Lenzo N, Ficaro, NP, Kritzman JN, Corbett JR. Clinical comparison of Profile attenuation correction and the Michigan modified STEP methods [abstract]. J Nucl Cardiol 2001; 8: S19.
Links JM, Becker LC, Rigo P, Taillefer R, Hanelin L, Anstett F, et al. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicenter trial. J Nucl Cardiol 2000; 7: 414–25.
Matsunari I, Boning G, Ziegler SI, Nekolla SG, Stollfuss JC, Kosa I, et al. Attenuation-corrected Tc-99m tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using F-18 fluorodeoxyglucose. J Am Coll Cardiol 1998; 32: 927–35.
Matsunari I, Boning G, Ziegler SI, Kosa I, Nekolla SG, Ficaro EP, et al. Attenuation corrected rest thallium-201/stress technetium 99m sestamibi myocardial SPECT in normals. J Nucl Cardiol 1998; 5: 48–55.
Miles J, Cullom SJ, Case JA. An introduction to attenuation correction. J Nucl Cardiol 1999; 6: 449–57.
Prvulovich EM, Lonn AHR, Bomnji JB, Jarritt PH, Ell PJ. Effect of attenuation correction on myocardial thallium-201 distribution in patients with a low likelihood of coronary artery disease. Eur J Nucl Med 1997; 24: 266–75.
Vidal R, Buvat I, Darcourt J, Migneco O, Desvignes P, Baudouy M, et al. Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of Tl-201 myocardial perfusion images. J Nucl Med 1999; 40: 1301–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hendel, R.C., Corbett, J.R., Cullom, S.J. et al. American society of nuclear cardiology and society of nuclear medicine joint position statement. J Nucl Cardiol 9, 135–143 (2002). https://doi.org/10.1067/mnc.2002.120680
Issue Date:
DOI: https://doi.org/10.1067/mnc.2002.120680